New kit offers researchers and development teams a meaningful advance in expression speed and output BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch of ...

Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A and IPO activity, ...

Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.

This genetic disorder treatment developer's stock hit a buy point after the biotech's first-quarter earnings report last week ...

This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S.

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm. Moderna Shares Have Rallied. Why the Stock Could Climb Another 30%. Following a robust rally, Moderna ...

BioNTech is one of the most recent companies to announce cuts, but the pace of job losses is slowing. There have been over 40 rounds of layoffs announced this year as of April 30, compared to more ...

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...

In 2023, ReNAgade Therapeutics launched with $300 million to exploit an “all in one” technology solution for RNA-based therapies. That same year, Tome Biosciences emerged from stealth with $213 ...

Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to ...

An expert from Northway Biotech and Lithuania’s Minister of Economy and Innovation talk about how the country is poised to be ...